Consistently, the trypan blue staining (Fig. 1g, h) and Annexin V-FITC/PI double staining assay (Fig. 1i-j) results provided evidences to support that high-dose doxorubicin specifically inhibited cell viability and promoted cell apoptosis in DS-BC cells compared to the DR-BC cells. Here, ANXA5 is linked to breast cancer.